Oxcarbazepine CAS 28721-07-5 Assay >99.0% API Anticonvulsant
Leading Supplier of Oxcarbazepine Intermediates
Oxcarbazepine CAS 28721-07-5
10-Methoxyiminostilbene CAS 4698-11-7
Please Contact: alvin@ruifuchem.com
| Chemical Name | Oxcarbazepine |
| Synonyms | 10,11-Dihydro-10-oxo-5H-Dibenzo[b,f]azepine-5-Carboxamide; Aurene; GP 47680; Oxecarb; Oxetol; Trileptal |
| CAS Number | 28721-07-5 |
| CAT Number | RF2692 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C15H12N2O2 |
| Molecular Weight | 252.27 |
| Melting Point | 222.0~228.0℃(dec.)(lit.) |
| Boiling Point | 457.2±55.0℃ |
| Density | 1.329±0.06 g/cm3 |
| Solubility | Soluble in Dimethylformamide, Methanol and Ethanol. Insoluble in Water |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White or Almost White Crystalline Powder |
| Identification | IR & UV & HPLC |
| Purity / Analysis Method | >99.0% (HPLC) |
| Purity / Analysis Method | >99.0% (With Total Nitrogen) |
| Melting Point | 222.0~228.0℃ |
| Loss on Drying | <0.30% |
| Residue on Ignition | <0.20% |
| Related Substances | |
| Carbamazepine | <0.20% |
| Total Unknown Impurities | <0.50% |
| Total Impurities | <1.00% |
| Infrared Spectrum | Conforms to Structure |
| Proton NMR Spectrum | Conforms to Structure |
| Test Standard | Enterprise Standard |
| Usage | Anticonvulsant |
Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
How to Purchase? Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Russia, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Oxcarbazepine (CAS: 28721-07-5) is an anticonvulsant drug primarily used in the treatment of epilepsy. There is some evidence for oxcarbazepine as a mood-stabilizing agent and thus, it can be used as add-on therapy for bipolar disorder in patients that have failed or are unable to tolerate approved treatments. Oxcarbazepine is used alone or in combination with other medications to control certain types of seizures. Oxcarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain. It is indicated as monotherapy or adjunctive therapy for partial seizures in adults with epilepsy, as monotherapy for the treatment of partial seizures in children 4 years of age or older, and as adjunct therapy in children 2 to 4 years of age. Oxcarbazepine is chemically and pharmacologically closely related to carbamazepine, but it has much less capacity to induce drug-metabolizing enzymes. This property decreases the problems associated with drug interactions when oxcarbazepine is used in combination with other drugs. The clinical uses and adverse effect profile of oxcarbazepine appear to be similar to those of carbamazepine. Oxcarbazepine was approved for use as an anticonvulsant in Denmark in 1990, Spain in 1993, Portugal in 1997, and eventually for all other EU countries in 1999. It was approved in the US in 2000. Oxcarbazepine is a second-generation AED supplied under the proprietary brand name of Trileptal® (Novartis, Basel) in the UK and USA.
